SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Donald Trump behind a podium
Government
Lilly, Pfizer Execs Sing Optimistic Tune on Incoming Admin After Trump Dinner
A week after dining with Trump and his team at Mar-a-Lago, leaders at Pfizer and Eli Lilly have publicly stated that they intend to collaborate with the incoming administration on key issues affecting the pharma industry.
December 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Illustration showing woman starting down curved path with markers toward goal marked by flag
Career Advice
Career Coach: Boost Your Career With This End-of-Year Action Plan
Learn how to leverage your end-of-year downtime to document achievements, update your professional presence and prepare for a successful 2025.
December 12, 2024
 · 
5 min read
 · 
Carina Clingman
Contemporary art collage of human hands holding a arrow pointing up, graphs and diagrams. Concept of profit, making money, business. Copy space.
Prostate cancer
Candel Stock Skyrockets on Promising Phase III Prostate Cancer Data
Candel’s trial was conducted under the FDA’s Special Protocol Assessment program, meaning that its data could be used as a basis for a regulatory application.
December 12, 2024
 · 
3 min read
 · 
Tristan Manalac
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former CytoDyn Official Found Guilty of Securities Fraud
Former president and CEO of CytoDyn Nader Pourhassan along with Kazem Kazempour, former CEO of the CRO running CytoDyn’s trials, are awaiting sentencing but could face up to 20 years in prison for each count of securities and wire fraud and insider trading.
December 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Vector Illustration of pharmacy drug health tablet pharmaceutical, Realistic pills blister pack medical tabs. Eps 10 Vector.
Policy
Pushback Against IRA’s Controversial ‘Pill Penalty’ Faces Stiff Budgetary Headwinds
The EPIC Act has been proposed with bipartisan and industry support to give small molecule drugs the same protection against price negotiation as biologics, but concerns over how to balance the federal budget could prevent a short-term fix to the IRA.
December 11, 2024
 · 
5 min read
 · 
Ben Hargreaves
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Immunology and inflammation
Acelyrin Terminates Izokibep After Failed Phase IIb/III Uveitis Data
The discontinuation caps off a turbulent development path for izokibep, which in September 2023 produced disappointing results from Phase IIb/III study in hidradenitis suppurativa that was found to have had dosing errors.
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
3d rendering of a white open doorway with broken damaged space rocket on light pink background. Heaven doorway. Science and technology. Research and development.
IPO
After Making the IPO Jump, Biotechs Landed On a Slippery Slope
Around 25 companies have gone public this year, most of them in the early months. Most have tumbled from their original offer price.
December 11, 2024
 · 
1 min read
 · 
Annalee Armstrong
Сontemporary art collage of human hands holding french fries or chips. Modern design. Copy space for ad.
Mergers & Acquisitions
Pharma Has Kept M&A Spending Small This Year, With Just One Deal Topping $5B
By far, the largest acquisition of 2024 was Novo Holdings’ yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion. Outside of that, the leading pharmaceutical companies kept to less than $5 billion per deal.
December 11, 2024
 · 
4 min read
 · 
Annalee Armstrong
Medical technology. Doctor holding health icon with dna, electronic medical record. Digital healthcare and research with global network connection on hologram virtual screen, insurance, digital health technology
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
 · 
4 min read
 · 
BioSpace Insights
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS